Victory Capital Management Inc Axcella Health Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.94 - $7.7 $4,354 - $11,403	-1,481 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.25 - $5.24 $537 - $1,252	-239 Reduced 13.9%	1,481 $5,000
Q4 2019 Feb 04, 2020	BUY	$3.08 - $5.9 $3,283 - $6,289	1,066 Added 163.0%	1,720 $8,000
Q3 2019 Nov 12, 2019	BUY	$5.25 - $9.26 $3,433 - $6,056	654 New	654 $4,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.